Alibaba Health Information Technology (FRA:TWYA) Current Accrued Expense: €34 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TWYA Alibaba Health Information Technology Ltd FRA:TWYA
79 GF Score
Price €5.40
GF Value €9.58
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology Current Accrued Expense?

Alibaba Health Information Technology FRA:TWYA +5.66% 79 Current Accrued Expense is €34 Mil as of Mar. 2026. GuruFocus rates FRA:TWYA with a GF Score™ of 79/100 and a GF Value™ of €9.58 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Alibaba Health Information Technology's Current Accrued Expense for the quarter that ended in Mar. 2026 was €34 Mil.

Alibaba Health Information Technology's quarterly Current Accrued Expense increased from Mar. 2025 (€27 Mil) to Sep. 2025 (€121 Mil) but then declined from Sep. 2025 (€121 Mil) to Mar. 2026 (€34 Mil).

Alibaba Health Information Technology's annual Current Accrued Expense increased from Mar. 2024 (€12 Mil) to Mar. 2025 (€27 Mil) and increased from Mar. 2025 (€27 Mil) to Mar. 2026 (€34 Mil).

Alibaba Health Information Technology Current Accrued Expense Related Terms

Alibaba Health Information Technology Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology Current Accrued Expense Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.06 23.58 11.88 27.46 33.71

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.88 139.19 27.46 121.22 33.71
FRA:TWYA
79GF Score
Alibaba Health Information Technology Ltd FRA:TWYA
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of €34 Mil mean?
Alibaba Health Information Technology (FRA:TWYA) has a Current Accrued Expense of €34 Mil as of Mar. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Alibaba Health Information Technology and its competitors.
Is Alibaba Health Information Technology's Current Accrued Expense too high?
Alibaba Health Information Technology's current Current Accrued Expense is €34 Mil. Overall, Alibaba Health Information Technology has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Current Accrued Expense compare to competitors?
Alibaba Health Information Technology's Current Accrued Expense of €34 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Healthcare Providers & Services company?
A good Current Accrued Expense depends on the Healthcare Providers & Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Alibaba Health Information Technology and its competitors. Alibaba Health Information Technology's current Current Accrued Expense is €34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (FRA:TWYA) is currently considered Significantly Undervalued. The stock's GF Value™ is €9.58, compared to a current price of €5.40 — trading 43.6% below its estimated fair value. The current Current Accrued Expense is €34 Mil. Alibaba Health Information Technology's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Alibaba Health Information Technology (FRA:TWYA), the current Current Accrued Expense is €34 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (FRA:TWYA) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of €5.40 is trading 43.6% below its estimated GF Value™ of €9.58. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for FRA:TWYA:

  • Current Accrued Expense: €34 Mil
  • GF Value™: €9.58 vs. price of €5.40 (43.6% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the FRA:TWYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alibaba Health Information Technology Business Description

Address Zone 4, 30th Floor, Greenland Center, Building 9, Wangjing East Park, Chaoyang District, Beijing, CHN
Alibaba Health Information Technology Ltd is a Chinese healthcare platform operating primarily under the Alibaba Group umbrella. Its core business is pharmaceutical and healthcare e-commerce, spanning both a direct-to-consumer model with its own inventory and a third-party marketplace for merchants, accessible through Alibaba's Tmall and Taobao apps as well as Alipay. The company also operates an internet healthcare segment offering online consultations, prescription fulfillment, and chronic disease management through its own medical service platforms. Its product range covers prescription drugs, over-the-counter medicines, traditional Chinese medicine, health supplements, medical devices, and contact lenses. Customers include individual consumers across China and pharmaceutical manufacturers, distributors, and retail pharmacies that use its platform. Revenue derives mainly from product sales, marketplace commissions, and service fees, with e-commerce accounting for the large majority of total revenue. Alibaba Group remains its controlling shareholder.
79GF Score

Get the complete analysis for FRA:TWYA

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.40
Price
€9.58
GF Value